Appili Therapeutics Inc. Stock OTC Markets
Stocks
APLIF
CA03783R1073
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0110 USD | +8.37% |
|
+7.84% | -25.68% |
| Market Cap | 1.32M 940K 826K 768K 704K 90.51M 1.34M 9.12M 3.56M 44.5M 3.53M 3.45M 154M | P/E 2025 |
-1.62x | P/E 2026 | -0.44x |
|---|---|---|---|---|---|
| Enterprise Value | 14.22M 10.1M 8.87M 8.25M 7.57M 972M 14.44M 97.94M 38.26M 478M 37.91M 37.09M 1.65B | EV / Sales 2025 |
152,429,607x | EV / Sales 2026 | 60,946,081x |
| Free-Float |
99.94% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +8.37% | ||
| 1 week | +7.84% | ||
| 1 month | -2.65% | ||
| 3 months | -16.67% | ||
| 6 months | -26.17% | ||
| Current year | -25.68% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.01 |
| Current year | 0.01 | | 0.02 |
| 1 year | 0.01 | | 0.03 |
| 3 years | 0.01 | | 0.07 |
| 5 years | 0.01 | | 0.9 |
| 10 years | 0.01 | | 1.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Don Cilla
CEO | Chief Executive Officer | 65 | 01/11/2022 |
Kenneth Howling
DFI | Director of Finance/CFO | 68 | 16/11/2021 |
Arthur Baran
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 27/01/2020 | |
Prakash Gowd
BRD | Director/Board Member | 62 | 13/11/2023 |
Brian Bloom
CHM | Chairman | 50 | 07/05/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.37% | +7.84% | - | - | 940K | |
| +0.93% | +6.97% | +59.60% | +68.35% | 57.28B | |
| -1.92% | +6.03% | +40.64% | +83.42% | 54.99B | |
| -0.46% | -1.29% | +2.86% | +428.78% | 23.18B | |
| -2.97% | -2.35% | -22.53% | -16.40% | 22.59B | |
| -0.36% | +5.73% | +24.13% | -6.24% | 20.46B | |
| -1.34% | +0.51% | +26.03% | -29.41% | 17.56B | |
| -1.44% | +5.67% | +38.77% | +504.71% | 15.67B | |
| -1.30% | -5.02% | +170.77% | +291.37% | 14.46B | |
| -0.50% | -0.98% | +21.43% | +180.07% | 13.92B | |
| Average | -0.10% | +1.28% | +40.19% | +167.18% | 26.68B | |
| Weighted average by Cap. | -0.87% | +2.10% | +39.70% | +133.49% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 0.1 0.07 0.06 0.06 0.05 6.87 0.1 0.69 0.27 3.38 0.27 0.26 11.68 | 0.24 0.17 0.15 0.14 0.13 16.7 0.25 1.68 0.66 8.21 0.65 0.64 28.38 |
| Net income | -2.62M -1.86M -1.64M -1.52M -1.4M -179M -2.67M -18.08M -7.06M -88.24M -7M -6.85M -305M | -4.24M -3.01M -2.64M -2.46M -2.26M -290M -4.31M -29.21M -11.41M -143M -11.3M -11.06M -493M |
| Net Debt | 11.07M 7.86M 6.9M 6.42M 5.89M 757M 11.24M 76.22M 29.78M 372M 29.5M 28.86M 1.29B | 12.9M 9.16M 8.04M 7.48M 6.86M 882M 13.1M 88.82M 34.7M 434M 34.38M 33.64M 1.5B |
Employees
7
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- APLI Stock
- APLIF Stock
Select your edition
All financial news and data tailored to specific country editions
